loadpatents
Patent applications and USPTO patent grants for Dasseux; Jean-Louis.The latest application filed is for "cer-001 therapy for treating kidney disease".
Patent | Date |
---|---|
Lipoprotein complexes and manufacturing and uses thereof Grant 11,376,309 - Dasseux , et al. July 5, 2 | 2022-07-05 |
Cer-001 Therapy For Treating Kidney Disease App 20210322448 - Dasseux; Jean-Louis ;   et al. | 2021-10-21 |
Apomers App 20210145932 - DASSEUX; Jean-Louis | 2021-05-20 |
Lipoprotein Complexes And Manufacturing And Uses Thereof App 20190298800 - DASSEUX; Jean-Louis ;   et al. | 2019-10-03 |
Lipoprotein complexes and manufacturing and uses thereof Grant 10,328,119 - Dasseux , et al. | 2019-06-25 |
Lipoprotein complexes and manufacturing and uses thereof Grant 10,322,163 - Dasseux , et al. | 2019-06-18 |
Cargomers App 20190048049 - DASSEUX; Jean-Louis | 2019-02-14 |
Apomers App 20190046608 - DASSEUX; Jean-Louis | 2019-02-14 |
Hdl Therapy Markers App 20180203025 - DASSEUX; Jean-Louis ;   et al. | 2018-07-19 |
Apolipoprotein A-I mimics Grant 9,981,008 - Dasseux , et al. May 29, 2 | 2018-05-29 |
Charged Lipoprotein Complexes And Their Uses App 20170182121 - DASSEUX; Jean-Louis | 2017-06-29 |
Charged lipoprotein complexes and their uses Grant 9,567,388 - Dasseux February 14, 2 | 2017-02-14 |
Apolipoprotein A-i Mimics App 20160324923 - Dasseux; Jean-Louis ;   et al. | 2016-11-10 |
Apolipoprotein A-I mimics Grant 9,388,232 - Dasseux , et al. July 12, 2 | 2016-07-12 |
Lipoprotein Complexes And Manufacturing And Uses Thereof App 20160095901 - DASSEUX; Jean-Louis ;   et al. | 2016-04-07 |
Lipoprotein complexes and manufacturing and uses thereof Grant 9,187,551 - Dasseux , et al. November 17, 2 | 2015-11-17 |
Hdl Therapy Markers App 20150316566 - DASSEUX; Jean-Louis ;   et al. | 2015-11-05 |
Lipoprotein Complexes And Manufacturing And Uses Thereof App 20150152164 - DASSEUX; Jean-Louis ;   et al. | 2015-06-04 |
Apolipoprotein A-i Mimics App 20150141330 - Dasseux; Jean-Louis ;   et al. | 2015-05-21 |
Apolipoprotein A-I mimics Grant 8,993,597 - Dasseux , et al. March 31, 2 | 2015-03-31 |
Lipoprotein Complexes And Manufacturing And Uses Thereof App 20140213501 - DASSEUX; Jean-Louis ;   et al. | 2014-07-31 |
Charged Lipoprotein Complexes And Their Uses App 20140206600 - DASSEUX; Jean-Louis | 2014-07-24 |
Charged lipoprotein complexes and their uses Grant 08617615 - | 2013-12-31 |
Charged lipoprotein complexes and their uses Grant 8,617,615 - Dasseux December 31, 2 | 2013-12-31 |
Apolipoprotein A-i Mimics App 20130231459 - Dasseux; Jean-Louis ;   et al. | 2013-09-05 |
Apolipoprotein A-I mimics Grant 8,378,068 - Dasseux , et al. February 19, 2 | 2013-02-19 |
Charged Lipoprotein Complexes And Their Uses App 20120245328 - Dasseux; Jean-Louis | 2012-09-27 |
Lipoprotein Complexes And Manufacturing And Uses Thereof App 20120232005 - Dasseux; Jean-Louis ;   et al. | 2012-09-13 |
Charged lipoprotein complexes and their uses Grant 8,206,750 - Dasseux June 26, 2 | 2012-06-26 |
Method of treating dyslipidemic disorder Grant 7,994,120 - Dasseux , et al. August 9, 2 | 2011-08-09 |
Apolipoprotein A-i Mimics App 20100267631 - DASSEUX; JEAN-LOUIS ;   et al. | 2010-10-21 |
Multimeric apoprotein agonists Grant 7,566,695 - Dasseux , et al. July 28, 2 | 2009-07-28 |
Compositions And Methods For Producing Apolipoprotein App 20080293102 - OXENDER; Maritza ;   et al. | 2008-11-27 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20080058270 - Dasseux; Jean-Louis ;   et al. | 2008-03-06 |
Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder App 20080050351 - Dasseux; Jean-Louis ;   et al. | 2008-02-28 |
Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,312,190 - Dasseux , et al. December 25, 2 | 2007-12-25 |
Multimeric Apo A-I agonist compounds Grant 7,307,058 - Dasseux , et al. December 11, 2 | 2007-12-11 |
Ketone compounds and compositions for cholesterol management and related uses Grant 7,304,093 - Dasseux , et al. December 4, 2 | 2007-12-04 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,273,848 - Dasseux , et al. September 25, 2 | 2007-09-25 |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,250,407 - Dasseux , et al. July 31, 2 | 2007-07-31 |
Peptide/Lipid Complex Formation by Co-Lyphilization App 20070167351 - Dasseux; Jean-Louis | 2007-07-19 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,211,565 - Dasseux , et al. May 1, 2 | 2007-05-01 |
Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders Grant 7,189,689 - Dasseux , et al. March 13, 2 | 2007-03-13 |
Peptide/lipid complex formation by co-lyophilization Grant 7,189,411 - Dasseux March 13, 2 | 2007-03-13 |
Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria App 20070048823 - Dasseux; Jean-Louis | 2007-03-01 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 7,157,425 - Dasseux , et al. January 2, 2 | 2007-01-02 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20060252694 - Dasseux; Jean-Louis ;   et al. | 2006-11-09 |
Charged lipoprotein complexes and their uses App 20060217312 - Dasseux; Jean-Louis | 2006-09-28 |
Methods of using non-human animal Apoliprotein A-I protein App 20060014692 - Zhu; Lingyu ;   et al. | 2006-01-19 |
Methods of using non-human animal Apolipoprotein A-I protein Grant 6,953,840 - Zhu , et al. October 11, 2 | 2005-10-11 |
Multimeric Apo A-I agonist compounds App 20050215467 - Dasseux, Jean-Louis ;   et al. | 2005-09-29 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20050203284 - Dasseux, Jean-Louis ;   et al. | 2005-09-15 |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20050148513 - Dasseux, Jean-Louis ;   et al. | 2005-07-07 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,900,177 - Dasseux , et al. May 31, 2 | 2005-05-31 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20050080013 - Dasseux, Jean-Louis ;   et al. | 2005-04-14 |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,844,327 - Dasseux , et al. January 18, 2 | 2005-01-18 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20040198662 - Dasseux, Jean-Louis ;   et al. | 2004-10-07 |
Multimeric Apo A-I agonist compounds App 20040181034 - Dasseux, Jean-Louis ;   et al. | 2004-09-16 |
Multimeric Apoa-I agonist compounds Grant 6,753,313 - Dasseux , et al. June 22, 2 | 2004-06-22 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,734,169 - Dasseux , et al. May 11, 2 | 2004-05-11 |
Methods of using non-human animal Apolipoprotein A-I protein App 20040077541 - Zhu, Lingyu ;   et al. | 2004-04-22 |
Multimeric Apo A-I agonist compounds Grant 6,716,816 - Dasseux , et al. April 6, 2 | 2004-04-06 |
Apolipoprotein A-i Agonists And Their Use To Treat Dyslipidemic Disorders App 20040029807 - Dasseux, Jean-Louis ;   et al. | 2004-02-12 |
Mimics of acyl coenzyme-A comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses App 20030236213 - Dasseux, Jean-Louis ;   et al. | 2003-12-25 |
Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses App 20030236212 - Dasseux, Jean-Louis ;   et al. | 2003-12-25 |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20030208059 - Dasseux, Jean-Louis ;   et al. | 2003-11-06 |
Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders App 20030203842 - Dasseux, Jean-Louis ;   et al. | 2003-10-30 |
Method of treating dyslipidemia Grant 6,630,450 - Dasseux , et al. October 7, 2 | 2003-10-07 |
Branched multimeric Apo A-I agonist compounds Grant 6,602,854 - Dasseux , et al. August 5, 2 | 2003-08-05 |
Apolipoprotein A-I agonist compounds Grant 6,573,239 - Dasseux , et al. June 3, 2 | 2003-06-03 |
Peptide/lipid complex formation by co-lyophilization App 20030099714 - Dasseux, Jean-Louis | 2003-05-29 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20030060604 - Dasseux, Jean-Louis ;   et al. | 2003-03-27 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders App 20030008827 - Dasseux, Jean-Louis ;   et al. | 2003-01-09 |
Peptide/lipid complex formation by co-lyophilization Grant 6,455,088 - Dasseux September 24, 2 | 2002-09-24 |
Lipid complexes of APO A-1 agonist compounds Grant 6,376,464 - Dasseux , et al. April 23, 2 | 2002-04-23 |
Method of treating septic shock Grant 6,329,341 - Dasseux , et al. December 11, 2 | 2001-12-11 |
Peptide/lipid complex formation by co-lyophilization Grant 6,287,590 - Dasseux September 11, 2 | 2001-09-11 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,265,377 - Dasseux , et al. July 24, 2 | 2001-07-24 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,046,166 - Dasseux , et al. April 4, 2 | 2000-04-04 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,037,323 - Dasseux , et al. March 14, 2 | 2000-03-14 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders Grant 6,004,925 - Dasseux , et al. December 21, 1 | 1999-12-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.